Debra L. Beck, MSc, and Eugene Braunwald, MD There are few treatment options for patients with secondary tricuspid regurgitation (TR). Recently, small studies have shown that the Cardioband tricuspid valve reconstruction system (Edwards Lifesciences) can be safely used to treat severe TR. This transcatheter device mimics the surgical annuloplasty approach and has received CE approvalMORE

As with other surgical specialties, responsible pain management and responsible utilization of opioids has been deficient historically, but has garnered much attention and effort recently to reduce the risk of diversion and overdose. A comprehensive review of the knowledge we currently have will guide clinicians who actively manage pain. MORE

Debra L. Beck, MSc, and Eugene Braunwald, MD Insights from the COMPLETE trial In the COMPLETE trial (Complete Versus Culprit-Only Revascularization to Treat Multi-Vessel Disease After Early PCI for STEMI), staged nonculprit lesion percutaneous coronary intervention (PCI) reduced major cardiovascular events in patients with ST-segment–elevation myocardial infarction (STEMI) and multivessel coronary artery disease (CAD) comparedMORE

Addition to Value-Added Roles for Medical Students Written by Victoria Stagg Elliott, MA; Jed D. Gonzalo, MD, MSc; Maya M. Hammoud, MD, MBA; Gregory W. Schneider, MD The ongoing COVID-19 pandemic and the increased focus on racial justice brought on by the murder of George Floyd in May 2020 and numerous other incidents of excessiveMORE